What We're Reading: Page 46
Industry reads hand-picked by our editors
Sep 04, 2024
-
The New Yorker
How A.I. Teaches Machines to Discover Drugs
-
Axios
Startup raises $191 million to edit pig organs for human transplant
-
The Wall Street Journal
‘She Didn’t Seem Right Yet’: The Deadly Threat to New Mothers
-
Fierce Biotech
Lilly, Haya ink $1B biobuck obesity pact to search dark genome
Sep 03, 2024
-
Bloomberg
Bayer Kidney Drug Helps Treat Common Form of Heart Failure
-
The Washington Post
Coronavirus vaccines are now pricey without insurance as CDC access program expires
-
Stat
A cancer survivor’s journey from pharma exec to patient advocate
-
Financial Times
The Covid-era tech that could reinvent cancer care
Aug 30, 2024
-
The Wall Street Journal
The Far-Reaching Ripple Effects of a Discredited Cancer Study
-
The New York Times
The State That Chose to Cover Obesity Drugs for Its Poor, but Not Its Own Employees
-
C&EN
How fledgling firms coexist in biotech incubators
Aug 29, 2024
Aug 28, 2024
Aug 27, 2024
-
The Washington Post
How stem cell therapy freed a woman from diabetes
-
The Wall Street Journal
This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future
-
CNBC
Martin Shkreli must surrender Wu-Tang Clan album copies
Aug 26, 2024
-
Financial Times
Siemens Healthineers boosts cancer imaging with €200mn Novartis deal
-
The New York Times
Why Mpox Vaccines Aren’t Flowing to Africans in Desperate Need
-
The Telegraph
Second Alzheimer’s drug expected to be blocked for NHS use
-
Fierce Pharma
Bayer layoffs hit Switzerland with 150 cuts at Basel consumer health hub
Previous
